谷歌浏览器插件
订阅小程序
在清言上使用
VIPCreated with Sketch.

Trial in Progress: A First-in-Human Phase 1/2 Study of Hematopoietic Stem Cell Transplantation (HCT) with VOR33 (CD33-Deleted Allograft) Followed By Treatment with Gemtuzumab Ozogamicin (GO) in Patients with CD33+ Acute Myeloid Leukemia (AML) Who Are at High-Risk of Post-HCT Relapse

Brenda W. Cooper,Hyung C. Suh,Divya Koura,Guenther Koehne,Christina Cho,Nadia M. Bambace,Léa Bernard,Nirali N. Shah,Roland B. Walter,John F. DiPersio,Sritama Nath, Melissa M. Lee-Sundlov, Ali Lacy, Darren Stanizzi, Karen Kuhn,Jennifer S. Whangbo, Christopher Slapak,Glen D. Raffel

Blood（2022）

引用 1|浏览14
暂无评分
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要